Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | HROW | ANIP |
|---|---|---|
| Price | $30.62 | $71.93 |
| Change today | ▲ 0.89% | ▲ 0.57% |
| Market cap | $1.15B | $1.65B |
| Return, 3 months | -28.7% | -14.1% |
| Return, year to date | -37.5% | -8.9% |
| Return, 1 year | -22.9% | -21.5% |
| P/E (TTM) | -30.9 | 15.7 |
| P/B | 75.6 | 2.8 |
| P/E percentile vs own 5y | 47th | 62nd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +10.9% | +25.9% |
| Net profit growth (YoY) | -445.7% | +189.1% |
| Gross margin | 73.3% | 60.4% |
| Operating margin | -1.0% | 13.3% |
| Net margin | -13.5% | 10.2% |
| Return on equity | -114.8% | 19.3% |
| Analyst target vs. price | +110.1% | +45.8% |
| Analyst buy share | 100% | 71% |
| RSI (14) | 29 | 43 |
| 30-day volatility | 35.9% | 27.4% |
| Max drawdown, 1 year | -47.0% | -26.4% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
